These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29696728)

  • 21. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD.
    Barnes NC; Sharma R; Lettis S; Calverley PM
    Eur Respir J; 2016 May; 47(5):1374-82. PubMed ID: 26917606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
    Watz H; Tetzlaff K; Wouters EF; Kirsten A; Magnussen H; Rodriguez-Roisin R; Vogelmeier C; Fabbri LM; Chanez P; Dahl R; Disse B; Finnigan H; Calverley PM
    Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J; Chen B; Wu S; Wu F
    BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in Chronic Obstructive Pulmonary Disease? Results from Post Hoc Subgroup Analyses.
    Iqbal A; Barnes NC; Brooks J
    Clin Drug Investig; 2015 Oct; 35(10):685-8. PubMed ID: 26329916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial.
    Rabe KF; Watz H; Baraldo S; Pedersen F; Biondini D; Bagul N; Hanauer G; Göhring UM; Purkayastha D; Román J; Alagappan VKT; Saetta M
    Lancet Respir Med; 2018 Nov; 6(11):827-836. PubMed ID: 30224319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Jen R; Rennard SI; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2012; 7():587-95. PubMed ID: 23055709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
    Kamada T; Kaneko M; Tomioka H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
    Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
    Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients - a retrospective analysis.
    Greulich T; Tüffers J; Mager S; Eder A; Maxheim M; Alter P; Schmeck B; Vogelmeier CF
    Respir Res; 2020 May; 21(1):106. PubMed ID: 32375777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.
    Lapperre TS; Snoeck-Stroband JB; Gosman MM; Jansen DF; van Schadewijk A; Thiadens HA; Vonk JM; Boezen HM; Ten Hacken NH; Sont JK; Rabe KF; Kerstjens HA; Hiemstra PS; Timens W; Postma DS; Sterk PJ;
    Ann Intern Med; 2009 Oct; 151(8):517-27. PubMed ID: 19841453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emphysematous Phenotype is Characterized by Low Blood Eosinophils: A Cross-Sectional Study.
    Papaioannou AI; Kostikas K; Papaporfyriou A; Angelakis L; Papathanasiou E; Hillas G; Mazioti A; Bakakos P; Koulouris N; Papiris S; Loukides S
    COPD; 2017 Dec; 14(6):635-640. PubMed ID: 29099646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study.
    Contoli M; Baraldo S; Conti V; Gnesini G; Marku B; Casolari P; Scrigner P; Morelli P; Saetta M; Spanevello A; Papi A
    Respirology; 2020 Jan; 25(1):80-88. PubMed ID: 31251440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of budesonide on inflammatory status in COPD.
    Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
    COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world.
    Barnes N; Ishii T; Hizawa N; Midwinter D; James M; Hilton E; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2018; 13():433-440. PubMed ID: 29440882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease.
    Lapperre TS; Snoeck-Stroband JB; Gosman MM; Stolk J; Sont JK; Jansen DF; Kerstjens HA; Postma DS; Sterk PJ;
    Am J Respir Crit Care Med; 2004 Sep; 170(5):499-504. PubMed ID: 15172889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophil and T cell markers predict functional decline in COPD patients.
    D'Armiento JM; Scharf SM; Roth MD; Connett JE; Ghio A; Sternberg D; Goldin JG; Louis TA; Mao JT; O'Connor GT; Ramsdell JW; Ries AL; Schluger NW; Sciurba FC; Skeans MA; Voelker H; Walter RE; Wendt CH; Weinmann GG; Wise RA; Foronjy RF
    Respir Res; 2009 Nov; 10(1):113. PubMed ID: 19925666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD.
    Contoli M; Pauletti A; Rossi MR; Spanevello A; Casolari P; Marcellini A; Forini G; Gnesini G; Marku B; Barnes N; Rizzi A; Curradi G; Caramori G; Morelli P; Papi A
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 28982774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
    Pavord ID; Lettis S; Anzueto A; Barnes N
    Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.